Artrya Limited (AYA.AX)
AUD 0.67
(13.56%)
AUD 0.67
(13.56%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.18 AUD | -28.57% |
| 2023 | -0.14 AUD | 46.15% |
| 2022 | -0.26 AUD | -116.67% |
| 2021 | -0.12 AUD | -98.02% |
| 2020 | -0.06 AUD | -3089.47% |
| 2019 | -0.00 AUD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q4 | -0.05 AUD | 100.0% |
| 2024 FY | - AUD | -28.57% |
| 2024 Q1 | -0.04 AUD | -46.98% |
| 2024 Q3 | -0.05 AUD | -3.42% |
| 2024 Q2 | -0.04 AUD | 0.0% |
| 2023 FY | - AUD | 46.15% |
| 2023 Q2 | -0.04 AUD | 0.0% |
| 2023 Q4 | -0.03 AUD | 0.0% |
| 2023 Q1 | -0.04 AUD | 39.77% |
| 2023 Q3 | -0.03 AUD | 27.67% |
| 2022 Q4 | -0.07 AUD | 0.0% |
| 2022 FY | - AUD | -398.08% |
| 2022 Q3 | -0.07 AUD | -14.19% |
| 2022 Q2 | -0.06 AUD | 0.0% |
| 2022 Q1 | -0.06 AUD | -108.71% |
| 2021 FY | - AUD | -201.73% |
| 2021 Q3 | -0.03 AUD | 6.51% |
| 2021 Q4 | -0.03 AUD | 0.0% |
| 2021 Q1 | -0.03 AUD | 0.0% |
| 2021 Q2 | -0.03 AUD | 0.0% |
| 2020 FY | - AUD | -810.53% |
| 2019 FY | - AUD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Alcidion Group Limited | -0.01 AUD | -2712.5% |
| Beamtree Holdings Limited | -0.02 AUD | -894.475% |
| Cogstate Limited | 0.05 AUD | 481.356% |
| Careteq Limited | -0.01 AUD | -1465.217% |
| Doctor Care Anywhere Group PLC | -0.05 AUD | -250.195% |
| Emyria Limited | -0.03 AUD | -464.263% |
| Global Health Limited | -0.02 AUD | -696.46% |
| HITIQ Limited | -0.01 AUD | -1856.522% |
| Intelicare Holdings Limited | -0.01 AUD | -1700.0% |
| ImExHS Limited | -0.10 AUD | -80.0% |
| Mach7 Technologies Limited | -0.03 AUD | -443.807% |
| MedAdvisor Limited | 0.00 AUD | 13946.154% |
| Oakridge International Limited | -0.04 AUD | -317.633% |
| Opyl Limited | -0.02 AUD | -883.607% |
| PainChek Limited | -0.01 AUD | -3057.895% |
| Pro Medicus Limited | 0.79 AUD | 122.785% |
| Resonance Health Limited | 0.00 AUD | 45100.0% |
| Singular Health Group Ltd | -0.03 AUD | -484.416% |
| Total Brain Limited | -0.15 AUD | -20.0% |